Differentiating pulmonary hypertension associated with protein kinase inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12075
Abstract: Abstract Protein kinase inhibitors (PKIs) have been implicated in pulmonary vascular toxicities including risk factors for at least three of the five World Health Organization groups of pulmonary hypertension (PH). These toxicities include direct drug‐induced… read more here.
Keywords: protein kinase; pulmonary hypertension; differentiating pulmonary; kinase inhibitors ... See more keywords